Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

217 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Duration of COVID-19 mRNA Vaccine Effectiveness against Severe Disease.
Bansal D, Abdulmajeed J, Al-Shamali MHMA, Albayat SSA, Himatt SM, Cyprian FS, Chivese T, Mundodan JMA, Khogali HS, Baaboura R, Kaleeckal AH, Kandy MC, Latif AN, Al-Kuwari MG, Al-Romaihi HE, Al Khal A, Bertollini R, Al-Thani MH, Farag E, Doi SAR. Bansal D, et al. Among authors: doi sar. Vaccines (Basel). 2022 Jun 28;10(7):1036. doi: 10.3390/vaccines10071036. Vaccines (Basel). 2022. PMID: 35891199 Free PMC article.
Prevalence and determinants of symptomatic COVID-19 infection among children and adolescents in Qatar: a cross-sectional analysis of 11 445 individuals.
Musa OAH, Chivese T, Bansal D, Abdulmajeed J, Ameen O, Islam N, Xu C, Sallam MA, Albayat SS, Khogali HS, Ahmed SNN, Himatt SM, Nour M, Elberdiny AA, Musa A, Furuya-Kanamori L, Al-Romaihi HE, Doi SAR, Al-Thani MHJ, Abu Baker Abd Farag E. Musa OAH, et al. Among authors: doi sar. Epidemiol Infect. 2021 Jul 2;149:e193. doi: 10.1017/S0950268821001515. Epidemiol Infect. 2021. PMID: 34210371 Free PMC article.
Efficacy of chloroquine and hydroxychloroquine in treating COVID-19 infection: A meta-review of systematic reviews and an updated meta-analysis.
Chivese T, Musa OAH, Hindy G, Al-Wattary N, Badran S, Soliman N, Aboughalia ATM, Matizanadzo JT, Emara MM, Thalib L, Doi SAR. Chivese T, et al. Among authors: doi sar. Travel Med Infect Dis. 2021 Sep-Oct;43:102135. doi: 10.1016/j.tmaid.2021.102135. Epub 2021 Jul 12. Travel Med Infect Dis. 2021. PMID: 34265436 Free PMC article. Review.
Prevalence and determinants of symptomatic COVID-19 infection among children and adolescents in Qatar: a cross-sectional analysis of 11 445 individuals.
Musa OAH, Chivese T, Bansal D, Abdulmajeed J, Ameen O, Islam N, Xu C, Sallam MA, Albayat SS, Khogali HS, Ahmed SNN, Himatt SM, Nour M, Elberdiny AA, Abdallah AM, Furuya-Kanamori L, Al-Romaihi HE, Doi SAR, Al-Thani MHJ, Abd Farag EAB. Musa OAH, et al. Among authors: doi sar. Epidemiol Infect. 2021 Sep 14;149:e203. doi: 10.1017/S095026882100203X. Epidemiol Infect. 2021. PMID: 34517936 Free PMC article. No abstract available.
The prevalence of adaptive immunity to COVID-19 and reinfection after recovery - a comprehensive systematic review and meta-analysis.
Chivese T, Matizanadzo JT, Musa OAH, Hindy G, Furuya-Kanamori L, Islam N, Al-Shebly R, Shalaby R, Habibullah M, Al-Marwani TA, Hourani RF, Nawaz AD, Haider MZ, Emara MM, Cyprian F, Doi SAR. Chivese T, et al. Among authors: doi sar. Pathog Glob Health. 2022 Jul;116(5):269-281. doi: 10.1080/20477724.2022.2029301. Epub 2022 Jan 31. Pathog Glob Health. 2022. PMID: 35099367 Free PMC article.
Redefining effect modification.
Doi SA, Abdulmajeed J, Xu C. Doi SA, et al. J Evid Based Med. 2022 Sep;15(3):192-197. doi: 10.1111/jebm.12495. Epub 2022 Sep 22. J Evid Based Med. 2022. PMID: 36138553
217 results